SOW
NVCR icon

State of Wyoming’s NovoCure NVCR Stock Holding History

State of Wyoming’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,974
Closed -$102K – 1833
2024
Q2 		$102K Buy
+5,974
New +$105K 0.02% 999
2022
Q2 		– Sell
-781
Closed -$65K – 2060
2022
Q1 		$65K Buy
+781
New +$57.5K 0.03% 899

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State of Wyoming's NVCR Position: Q3 2024 in Review

State of Wyoming sold out of NovoCure (NVCR) in Q3 2024, closing a stake of 5,974 shares — an estimated $102K sold.

State of Wyoming first reported a position in NVCR in Q1 2022 and held it in 2 quarters. The position peaked at $102K in Q2 2024. 224 funds tracked by Wall St. Rank hold NVCR as of Q3 2024.

  • State of Wyoming reported no remaining NovoCure position as of Q3 2024 after selling out during the quarter.
  • State of Wyoming sold 5,974 NovoCure shares in Q3 2024, an estimated $102K.
  • State of Wyoming first reported a position in NovoCure in Q1 2022 and held it in 2 quarters.
  • State of Wyoming's NovoCure position peaked at $102K in Q2 2024.
  • 224 funds tracked by Wall St. Rank held NovoCure as of Q3 2024.

Based on State of Wyoming's 13F filing for Q3 2024, filed 14 Nov 2024.